Susanna Baracco
Overview
Explore the profile of Susanna Baracco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferroni E, Guzzinati S, Andreotti A, Baracco S, Baracco M, Bovo E, et al.
Front Oncol
. 2024 Jun;
14:1372271.
PMID: 38863631
Objective: We investigated whether there are differences in cancer incidence by geographical area of origin in North-eastern Italy. Methods: We selected all incident cases recorded in the Veneto Tumour Registry...
2.
Guzzinati S, Battagello J, Bovo E, Baracco M, Baracco S, Carpin E, et al.
PLoS One
. 2022 Dec;
17(12):e0279415.
PMID: 36548228
Population-based cancer registration methods are subject to internationally-established rules. To ensure efficient and effective case recording, population-based cancer registries widely adopt digital processing (DP) methods. At the Veneto Tumor Registry...
3.
Spila Alegiani S, Crisafulli S, Rossi P, Mancuso P, Salvarani C, Atzeni F, et al.
Rheumatology (Oxford)
. 2021 Apr;
60(SI):SI25-SI36.
PMID: 33856453
Objectives: To ascertain if the use of hydroxychloroquine(HCQ)/cloroquine(CLQ) and other conventional DMARDs (cDMARDs) and rheumatic diseases per se may be associated with COVID-19-related risk of hospitalization and mortality. Methods: This...
4.
Zorzi M, Battagello J, Selby K, Capodaglio G, Baracco S, Rizzato S, et al.
Gut
. 2021 Apr;
71(3):561-567.
PMID: 33789965
Background: The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy...
5.
Buja A, Rivera M, Zorzi M, Sperotto M, Baracco S, Italiano I, et al.
Acta Derm Venereol
. 2019 Oct;
100(1):adv00003.
PMID: 31580466
No abstract available.
6.
Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, et al.
Gut
. 2017 Nov;
67(12):2124-2130.
PMID: 29101260
Background: The long-term performance of colorectal cancer (CRC) screening programmes based on a 2-year faecal immunochemical test (FIT) is still unclear. Methods: In a sample of 50 to 69-year-olds repeatedly...
7.
Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, et al.
Eur J Cancer
. 2017 Sep;
85:160.
PMID: 28870467
No abstract available.
8.
Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, et al.
Eur J Cancer
. 2017 Feb;
75:109-116.
PMID: 28222306
Background: The objective of this study was to evaluate if mammography screening attendance is associated with a reduction in late-stage breast cancer incidence. Methods: The cohort included over 400,000 Italian...
9.
Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy
Rossi P, Carretta E, Mangone L, Baracco S, Serraino D, Zorzi M
J Med Screen
. 2017 Feb;
25(1):32-39.
PMID: 28195508
Objective In Italy, colorectal screening programmes using the faecal immunochemical test from ages 50 to 69 every two years have been in place since 2005. We aimed to measure the...
10.
Zorzi M, Mangone L, Sassatelli R, Baracco S, Budroni M, Castaing M, et al.
Epidemiol Prev
. 2015 Sep;
39(3 Suppl 1):115-25.
PMID: 26405783
We utilised the IMPATTO study's archives to describe the 2000-2008 colorectal cancer (CRC) incidence rate trends in Italy, once screening programmes based on the faecal immunochemical test were implemented in...